Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carbetocin versus oxytocin for prevention of postpartum hemorrhage after cesarean section
ISRCTN69805695Phase 4Completed
- Sponsor
- Beacon Pharmaceuticals
- Start
- Jan 2015
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in postpartum hemorrhage (PPH) comparing Carbetocin arm with Oxytocin arm (2 arms). Started Jan 2015; status: completed.
02
Drugs
carbetocinoxytocin
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on ISRCTN69805695.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN69805695.